Lipaglyn 4mg Tablet 10s

Noncirrhotic Non-Alcoholic Steatohepatitis | Non-alcoholic fatty liver disease | Diabetic dyslipidemia (high cholesterol in diabetes)

In Noncirrhotic Non-Alcoholic Steatohepatitis Noncirrhotic non-alcoholic steatohepatitis (NASH) is liver inflammation and damage caused by excess fat in the liver. Because of the damage, the liver doesn't work as well as it should. Lipaglyn Tablet reduces fat deposition thereby improving its overall functioning. In Non-alcoholic fatty liver disease Non-alcoholic fatty liver disease is a condition in which there is an increased buildup of fat in the liver. It affects people who drink little to no alcohol. Lipaglyn Tablet protects the liver and reduces the risk of liver failure. In Diabetic dyslipidemia (high cholesterol in diabetes) Lipaglyn Tablet helps in the management of high cholesterol, as well as blood sugar levels in people with type 2 diabetes. It is mainly used in people whose cholesterol levels are not controlled by statin therapy alone. By controlling high cholesterol levels, Lipaglyn Tablet helps reduce the risk of heart diseases.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you're worried about them. ['Indigestion, Abdominal distension, Weakness']

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lipaglyn Tablet may be taken with or without food, but it is better to take it at a fixed time.

Lipaglyn Tablet contains Saroglitazar, a dual action peroxisome proliferator-activated receptor (PPAR) inhibitor that aids in the management of high cholesterol, especially triglycerides, as well as blood sugar levels in people with type 2 diabetes. It acts by a unique mechanism in which it reduces the synthesis and secretion of triglycerides (a type of lipid or cholesterol in blood). It also improves insulin sensitivity of the body for better utilization of the existing insulin and hence lowers the blood sugar levels.

Alcohol

UNSAFE - It is unsafe to consume alcohol with Lipaglyn Tablet.

Pregnancy

CONSULT YOUR DOCTOR - Lipaglyn Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CAUTION - Lipaglyn Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving

SAFE - Lipaglyn Tablet does not usually affect your ability to drive.

Kidney

CONSULT YOUR DOCTOR - There is limited information available on the use of Lipaglyn Tablet in patients with kidney disease. Please consult your doctor.

Liver

CONSULT YOUR DOCTOR - There is limited information available on the use of Lipaglyn Tablet in patients with liver disease. Please consult your doctor.

If you miss a dose, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and take it at the next scheduled time. Do not double the dose.

Store below 25°C

Zydus Tower, Satellite Cross Roads,Ahmedabad � 380015 Gujarat, India.